These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 853089)
1. Rapid gas chromatographic determination of underivatized phenprocoumon in plasma. Schmitt KF; Jähnchen E J Chromatogr; 1977 Jan; 130():418-21. PubMed ID: 853089 [No Abstract] [Full Text] [Related]
2. A gas chromatographic method for the estimation of phenprocoumon, 3-(1-phenyl-propyl)-4-hydroxycoumarin (Marcoumar, Liquamar), in human serum or plasma. Brombacher PJ; Cremers HM; Mol MJ; Muijrers PH; Van der Plas PM; Verheesen PE Clin Chim Acta; 1977 Mar; 75(3):443-8. PubMed ID: 856495 [TBL] [Abstract][Full Text] [Related]
3. A specific and sensitive method for the determination of the anticoagulant phenprocoumon in plasma. Haefelfinger P J Chromatogr; 1979 Feb; 162(2):215-22. PubMed ID: 762222 [TBL] [Abstract][Full Text] [Related]
4. Phenprocoumon metabolites in human plasma; characterization by HPLC and GC-MS. de Vries JX; Zimmermann R; Harenberg J Eur J Clin Pharmacol; 1986; 29(5):591-4. PubMed ID: 3956564 [TBL] [Abstract][Full Text] [Related]
5. Determination of phenprocoumon, an anticoagulant, in human plasma. DeWolf FA; VanKempen GM Clin Chem; 1976 Oct; 22(10):1575-8. PubMed ID: 975498 [TBL] [Abstract][Full Text] [Related]
6. [Protein binding of drugs determined by continuous ultrafiltration. I. Protein binding of phenprocoumon]. Rehse K; Rothe M; Maurer R; Kinawi A Arch Pharm (Weinheim); 1981 Oct; 314(10):867-74. PubMed ID: 7305640 [No Abstract] [Full Text] [Related]
7. [Determination of the binding of chlorodiazepoxide, diazepam, nitrazepam and phenprocoumon to human and bovine serum albumin (author's transl)]. Teller C; Kinawi A Arch Pharm (Weinheim); 1979 Apr; 312(4):295-8. PubMed ID: 571707 [No Abstract] [Full Text] [Related]
8. [Studies on the interactions of chlordiazepoxide, nitrazepam, and diazepam with phenprocoumon (author's transl)]. Kinawi A; Baumgartl I Arzneimittelforschung; 1976; 26(11):2019-23. PubMed ID: 1037237 [TBL] [Abstract][Full Text] [Related]
9. Effect of serum protein binding on pharmacokinetics and anticoagulant activity of phenprocoumon in rats. Trenk D; Jähnchen E J Pharmacokinet Biopharm; 1980 Apr; 8(2):177-91. PubMed ID: 7431221 [No Abstract] [Full Text] [Related]
10. [Studies on the protein-binding of drugs with continuous ultrafiltration. 8. In vitro quantification of the interactions of phenprocoumon, warfarin and methylsulfinyl warfarin with phenylbutazone on human serum albumin]. Rehse K; Ehlert K Arch Pharm (Weinheim); 1986 Mar; 319(3):271-4. PubMed ID: 3718179 [No Abstract] [Full Text] [Related]
11. [Determination of 3-(1'-phenylpropyl)-4-hydroxycoumarin by means of high-performance liquid chromatography (HPLC) (author's transl)]. Kinawi A Arzneimittelforschung; 1977 Feb; 27(2):360-3. PubMed ID: 577154 [TBL] [Abstract][Full Text] [Related]
12. Optical studies on the mechanism of the interaction of the enantiomers of the antiocagulant drugs phenprocoumon and warfarin with human serum albumin. Brown NA; Jähnchen E; Müller WE; Wollert U Mol Pharmacol; 1977 Jan; 13(1):70-9. PubMed ID: 834186 [No Abstract] [Full Text] [Related]
13. [Determination of the protein binding of drugs by continuous ultrafiltration. 9. Comparison of the binding of nonsteroid antirheumatics to human serum albumin and their interaction with phenprocoumon]. Rehse K; Fiedler B Arch Pharm (Weinheim); 1989 Apr; 322(4):241-3. PubMed ID: 2751413 [TBL] [Abstract][Full Text] [Related]
14. Determination of the anticoagulant phenprocoumon in human plasma and urine by high-performance liquid chromatography. De Vries JX; Harenberg J; Walter E; Zimmermann R; Simon M J Chromatogr; 1982 Aug; 231(1):83-92. PubMed ID: 7119068 [TBL] [Abstract][Full Text] [Related]
15. Species-dependent stereospecific serum protein binding of the oral anticoagulant drug phenprocoumon. Schmidt W; Jähnchen E Experientia; 1978 Oct; 34(10):1323-5. PubMed ID: 104885 [TBL] [Abstract][Full Text] [Related]
16. Separation of the enantiomers of phenprocoumon and warfarin by high-performance liquid chromatography using a chiral stationary phase. Determination of the enantiomeric ratio of phenprocoumon in human plasma and urine. de Vries JX; Völker U J Chromatogr; 1989 Aug; 493(1):149-56. PubMed ID: 2778004 [TBL] [Abstract][Full Text] [Related]
17. The binding of phenprocoumon to human plasma proteins. Husted S; Andreasen F Acta Pharmacol Toxicol (Copenh); 1979 Sep; 45(3):206-14. PubMed ID: 506743 [TBL] [Abstract][Full Text] [Related]
18. Interaction of allopurinol with phenprocoumon in man. Jähnchen E; Meinertz I; Gilfrich HJ Klin Wochenschr; 1977 Aug; 55(15):759-61. PubMed ID: 895010 [TBL] [Abstract][Full Text] [Related]
19. Individualization of drug dosage during long-term treatment with phenprocoumon (Falithrom). Haustein KO; Richter M; Vogel G; Mittag E Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):372-6. PubMed ID: 689796 [TBL] [Abstract][Full Text] [Related]
20. A pharmacokinetic model of the adjustment of phenprocoumon (Falithrom) dosage. Barthel W Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):838-50. PubMed ID: 6083961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]